Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy

Oral lichen planus (OLP) is the most frequent oral lesion found in patients with hepatitis C virus (HCV) infection. The aims of this study were to investigate the prevalence of OLP among chronic hepatitis C patients, to clarify the role of HCV in the pathogenesis of OLP, and to assess its relationsh...

Full description

Bibliographic Details
Main Authors: Shin-Yu Lu, Liang-Ho Lin, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung
Format: Article
Language:English
Published: Elsevier 2009-12-01
Series:Journal of Dental Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S199179020960026X
_version_ 1817991280650616832
author Shin-Yu Lu
Liang-Ho Lin
Sheng-Nan Lu
Jing-Houng Wang
Chao-Hung Hung
author_facet Shin-Yu Lu
Liang-Ho Lin
Sheng-Nan Lu
Jing-Houng Wang
Chao-Hung Hung
author_sort Shin-Yu Lu
collection DOAJ
description Oral lichen planus (OLP) is the most frequent oral lesion found in patients with hepatitis C virus (HCV) infection. The aims of this study were to investigate the prevalence of OLP among chronic hepatitis C patients, to clarify the role of HCV in the pathogenesis of OLP, and to assess its relationship to transaminase levels. Materials and methods: Two groups of subjects were studied; 277 hepatitis C patients were examined for OLP (Group 1) and 5273 outpatients seeking dental care within 1 year were used as a control (Group 2) to determine the prevalence of OLP in the general population. The dental and hepatic records were collected and analyzed. Results: The prevalences of OLP were 4.7% (n = 13) in Group 1 and 2.0% (n = 104) in Group 2 and significantly differed (P = 0.002). All 13 OLP cases occurred in hepatitis C patients who had experienced elevated alanine transaminase levels of > 80 IU/L within the 2 previous years, regardless of whether they were treated with interferon-ribavirin combination therapy or not. There was a strong association between elevated transaminase levels and the development of HCV-related OLP lesions (P = 0.014). Of the 13 OLP patients, two were in the group with a sustained virologic response (SVR) to HCV therapy, two were in the group without an SVR, and nine were in the non-therapy group. The incidence of OLP in hepatitis C patients did not significantly differ between those who showed an SVR to HCV therapy and those who did not respond or did not receive therapy (P = 0.560). Conclusion: We concluded that: (1) elevation of transaminase levels is associated with the detection of HCV-related OLP, and (2) HCV-related OLP can remain unchanged for years after an SVR to HCV therapy. The findings revealed that the role of HCV in OLP pathogenesis is due to host factors induced by HCV rather than a direct cytopathic effect of HCV.
first_indexed 2024-04-14T01:11:08Z
format Article
id doaj.art-611669aac1d74cfc8c55d276a394de1d
institution Directory Open Access Journal
issn 1991-7902
language English
last_indexed 2024-04-14T01:11:08Z
publishDate 2009-12-01
publisher Elsevier
record_format Article
series Journal of Dental Sciences
spelling doaj.art-611669aac1d74cfc8c55d276a394de1d2022-12-22T02:21:04ZengElsevierJournal of Dental Sciences1991-79022009-12-014419119710.1016/S1991-7902(09)60026-XIncreased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapyShin-Yu Lu0Liang-Ho Lin1Sheng-Nan Lu2Jing-Houng Wang3Chao-Hung Hung4Oral Pathology and Family Dentistry Section, Department of Dentistry, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanOral Pathology and Family Dentistry Section, Department of Dentistry, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanDivision of Hepato-Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, TaiwanOral lichen planus (OLP) is the most frequent oral lesion found in patients with hepatitis C virus (HCV) infection. The aims of this study were to investigate the prevalence of OLP among chronic hepatitis C patients, to clarify the role of HCV in the pathogenesis of OLP, and to assess its relationship to transaminase levels. Materials and methods: Two groups of subjects were studied; 277 hepatitis C patients were examined for OLP (Group 1) and 5273 outpatients seeking dental care within 1 year were used as a control (Group 2) to determine the prevalence of OLP in the general population. The dental and hepatic records were collected and analyzed. Results: The prevalences of OLP were 4.7% (n = 13) in Group 1 and 2.0% (n = 104) in Group 2 and significantly differed (P = 0.002). All 13 OLP cases occurred in hepatitis C patients who had experienced elevated alanine transaminase levels of > 80 IU/L within the 2 previous years, regardless of whether they were treated with interferon-ribavirin combination therapy or not. There was a strong association between elevated transaminase levels and the development of HCV-related OLP lesions (P = 0.014). Of the 13 OLP patients, two were in the group with a sustained virologic response (SVR) to HCV therapy, two were in the group without an SVR, and nine were in the non-therapy group. The incidence of OLP in hepatitis C patients did not significantly differ between those who showed an SVR to HCV therapy and those who did not respond or did not receive therapy (P = 0.560). Conclusion: We concluded that: (1) elevation of transaminase levels is associated with the detection of HCV-related OLP, and (2) HCV-related OLP can remain unchanged for years after an SVR to HCV therapy. The findings revealed that the role of HCV in OLP pathogenesis is due to host factors induced by HCV rather than a direct cytopathic effect of HCV.http://www.sciencedirect.com/science/article/pii/S199179020960026Xhepatitis Cinterferonoral lichen planusribavirin
spellingShingle Shin-Yu Lu
Liang-Ho Lin
Sheng-Nan Lu
Jing-Houng Wang
Chao-Hung Hung
Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
Journal of Dental Sciences
hepatitis C
interferon
oral lichen planus
ribavirin
title Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
title_full Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
title_fullStr Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
title_full_unstemmed Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
title_short Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
title_sort increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon ribavirin therapy
topic hepatitis C
interferon
oral lichen planus
ribavirin
url http://www.sciencedirect.com/science/article/pii/S199179020960026X
work_keys_str_mv AT shinyulu increasedorallichenplanusinachronichepatitispatientassociatedwithelevatedtransaminaselevelsbeforeandafterinterferonribavirintherapy
AT liangholin increasedorallichenplanusinachronichepatitispatientassociatedwithelevatedtransaminaselevelsbeforeandafterinterferonribavirintherapy
AT shengnanlu increasedorallichenplanusinachronichepatitispatientassociatedwithelevatedtransaminaselevelsbeforeandafterinterferonribavirintherapy
AT jinghoungwang increasedorallichenplanusinachronichepatitispatientassociatedwithelevatedtransaminaselevelsbeforeandafterinterferonribavirintherapy
AT chaohunghung increasedorallichenplanusinachronichepatitispatientassociatedwithelevatedtransaminaselevelsbeforeandafterinterferonribavirintherapy